OQS
ORIC icon

Occudo Quantitative Strategies’s Oric Pharmaceuticals ORIC Stock Holding History

Occudo Quantitative Strategies’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,771
Closed -$50K – 1256
2022
Q3 		$50K Sell
15,771
-22,684
-59% -$90.8K ﹤0.01% 1093
2022
Q2 		$172K Buy
38,455
+1,464
+4% +$5.84K 0.01% 944
2022
Q1 		$198K Buy
+36,991
New +$333K 0.02% 946

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Occudo Quantitative Strategies's ORIC Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Oric Pharmaceuticals (ORIC) in Q4 2022, closing a stake of 15,771 shares — an estimated $50K sold.

Occudo Quantitative Strategies first reported a position in ORIC in Q1 2022 and held it in 3 quarters. The position peaked at $198K in Q1 2022. 65 funds tracked by Wall St. Rank hold ORIC as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Oric Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 15,771 Oric Pharmaceuticals shares in Q4 2022, an estimated $50K.
  • Occudo Quantitative Strategies first reported a position in Oric Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Oric Pharmaceuticals position peaked at $198K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.